The U.S. Food and Drug Administration (FDA) has published Commissioner Scott Gottlieb’s September 14, 2018, remarks delivered at the Pew Charitable Trusts on the issue of antimicrobial resistance, including the effects of antibiotics in animals raised for food production. Gottlieb indicated that the agency will release “a draft strategy, likely as a new guidance for industry, by the end of fiscal year 2020” to advise companies on “ensuring that medically important antimicrobials are labeled with appropriately defined durations of use.”

In addition, FDA’s Science Board will hold a public meeting on October 22, 2018, to hear the Center for Veterinary Medicine’s response to the board’s recommendations on the National Antibiotic Resistance Monitoring System. The board will also discuss “potential hazards and nutritional considerations in the production of food derived from animal cell culture technologies.”

About The Author

For decades, manufacturers, distributors and retailers at every link in the food chain have come to Shook, Hardy & Bacon to partner with a legal team that understands the issues they face in today's evolving food production industry. Shook attorneys work with some of the world's largest food, beverage and agribusiness companies to establish preventative measures, conduct internal audits, develop public relations strategies, and advance tort reform initiatives.